Tirzepatide has become a well-known option in medical weight management, but not every version of the medication is the same. Some patients may be offered a compounded formulation when an FDA-approved product does not meet their individual medical needs. That can raise practical questions about how the medication is prepared, how it should be used, and what patients should know before starting.
Compounded tirzepatide has started gaining some popularity here in Dallas, but before making the move to this type of treatment, there are a few important things to understand. From dosing and side effects to where the medication comes from, here are five things you should know before starting compounded tirzepatide.
1. There Should Be a Specific Reason for Using It
Compounding is intended to address an individual patient’s medical needs. It should not simply be viewed as another way to obtain a popular medication.
The FDA states that compounded drugs should be used when a patient’s medical needs cannot be met by an FDA-approved drug. Current FDA guidance also places restrictions on when compounders can make products that are essentially copies of commercially available medications.
This is important because the availability of compounded tirzepatide has changed as the FDA’s shortage policies have changed. In 2024, the FDA determined that the tirzepatide injection shortage had been resolved, and in 2026 it clarified that tirzepatide was no longer on the drug shortage list. The rules around compounding therefore depend on the applicable federal requirements and the circumstances of the individual prescription.
For patients, the practical takeaway is simple: ask your prescriber why a compounded formulation is appropriate for your particular situation.
2. Dosing and Instructions Need Careful Attention
One of the biggest concerns with compounded injectable medications is dosing. FDA has received reports of adverse events associated with dosing errors involving compounded GLP-1 medications, including reports involving compounded tirzepatide. Some patients have had problems understanding how much medication to measure or how frequently to administer it.
This is one area where patients should avoid making assumptions. Different compounded products may come in different concentrations or packaging, and the instructions may not look exactly like those for an FDA-approved injection pen. The prescribing information should be followed exactly, and any uncertainty about the amount to draw into a syringe, injection schedule, or dose increase should be addressed with the prescribing clinician or dispensing pharmacy.
The approach to compounded tirzepatide in Dallas at Genesis Lifestyle Medicine reflects this need for individualized care. The practice states that a licensed prescriber must consider a patient’s health history, goals, and clinical needs when deciding whether a compounded formulation is appropriate. That kind of evaluation is important because dosing and treatment decisions should be based on the individual rather than a one-size-fits-all schedule.
3. Consider Side Effects and Your Tolerance
Compounded tirzepatide does not remove the need to pay attention to how the body responds to treatment. Tirzepatide affects appetite regulation and glucose metabolism, and people can respond differently to medications that act on these pathways.
The FDA has received reports involving compounded tirzepatide in which patients experienced symptoms including nausea, vomiting, diarrhea, abdominal pain, and constipation. As of May 31, 2026, the agency had received more than 730 adverse-event reports associated with compounded tirzepatide, although the FDA notes that these reports do not always establish that the medication directly caused the event. (U.S. Food and Drug Administration)
That number should be viewed in context rather than as a measure of the likelihood that any one patient will experience a problem. Still, it shows why ongoing medical supervision matters. Significant or unexpected symptoms should be discussed with a healthcare professional rather than ignored or managed by changing the dose independently.
4. Where the Medication Comes From Matters
The source of a compounded medication deserves attention. Patients should have a prescription from a licensed healthcare professional and obtain the medication through a state-licensed pharmacy, according to FDA guidance.
Patients should also check that the medication arrives with clear instructions and appropriate packaging. Injectable GLP-1 medications may require refrigeration, so patients should know the storage requirements before using the medication.
If a shipment arrives warm when refrigeration is required, damaged, or missing important instructions, it is better to contact the dispensing pharmacy or healthcare provider before using it.
5. Compounded Medication Differs From FDA-Approved Products
FDA-approved medications go through a review process that evaluates their safety, effectiveness, quality, and manufacturing before approval. Compounded drugs do not go through that same premarket review. The FDA says compounded drugs may be appropriate when a patient’s medical needs cannot be met by an FDA-approved medication, but they should not be treated as interchangeable with an approved product simply because they contain the same active ingredient.
That distinction does not automatically mean a compounded medication is unsafe or unsuitable. It means patients should understand what they are being prescribed and why a compounded version is being considered.
The Key Takeaway
Compounded tirzepatide may be considered in certain circumstances, but starting treatment should involve more than simply receiving a prescription. Patients should understand why a compounded formulation is being considered, how their specific dose should be measured and administered, where the medication comes from, and what kind of follow-up will be provided.
The goal is not to make compounded medication sound either better or worse than it is. It has a place in certain areas of medical care, but it also has important differences from FDA-approved products that patients should understand.
A careful discussion with a licensed prescriber can help determine whether compounded tirzepatide is appropriate and what monitoring is needed once treatment begins.
